Home › Trial NCT05383898
Study to Evaluate D-1553 in Subjects With Lung Cancer
- Trial IDNCT05383898
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorInventisBio Co., Ltd
- Enrollment225
- Start date2021-03-16
- ConditionsNSCLC
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.